Trial Profile
A Real-World Evidence Study comparing Urinary Albumin Excretion with Sitagliptin to that of Sulfonylurea (su) as Add-on to Metformin in Patients with Type 2 Diabetes and Albuminuria:
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Apr 2018
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 29 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.